ClinicalTrials.gov
public full text
Public Domain
Radioimmunotherapy With 131I-L19SIP in Patients With Cancer
The aim of this Study Protocol is to provide a basis for the clinical development of 131I-L19SIP as an anti-cancer therapeutic agent, following the promising results of a Phase I study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Study of 18F-LNC1007 Injection PET/CT#846517
- Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis#1113094
- A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors.#847384
- Real World Pharmacokinetics of Immune Checkpoint Inhibitors#992775
- Radioimmunotherapy in Solid Tumors (PNRR-MCNT2-2023-12378239-Aim2)#279521
Record · ID 807234
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive